Clinical Trials
5 trialsNCT07603661 2026-05-22
Sintilimab Plus Chemotherapy as Induction Therapy for Unresectable Stage IIIC NSCLC
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT06620822 2024-10-01
Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical Trial
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Not yet recruiting
NCT06604351 2024-09-19
Example
Hunan Province Tumor Hospital
Phase 2 Not yet recruiting
NCT06221462 2024-01-25
PRIORITY
Ningbo No.2 Hospital
Phase 2 Not yet recruiting
NCT06198907 2024-01-10
JACKPOT33
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting